Enflame's Shanghai IPO surge

Enflame priced its Shanghai STAR Market IPO at 142.18 yuan per share, raising roughly 6.12 billion yuan (about $911 million) by selling approximately 43 million shares^[1]. When trading opened, the stock jumped straight to 410 yuan, spiked as high as 475 yuan intraday - a 234% gain over the offer price - and still closed 179% above issue price, valuing the company at roughly 170.9 billion yuan (about $25.5 billion)^[1]. The scramble to get in was just as extreme as the pop itself: the retail tranche was oversubscribed 4,073 times, with about 7 million individual investors submitting orders for 42.1 billion shares, leaving each applicant an allocation rate of just 0.025%^[2]. That kind of demand-to-supply ratio is less a stock debut than a lottery.

The debut instantly enriched Enflame's own largest shareholder: Tencent Holdings, whose roughly 17.95%-20% stake^[3]gained about 20% in value, to nearly 35 billion yuan, the moment trading opened^[1]. Huajin Securities analysts were candid about where the appeal actually comes from, crediting Enflame's position as one of China's leading cloud AI chipmakers "as well as Tencent's dual role as both a key customer and major shareholder," while flagging that the company still trails peers in revenue scale and gross margin^[2]. That dual role is not a footnote: Tencent accounted for roughly 84% of Enflame's 2025 revenue^[3], meaning the chipmaker's growth is substantially a function of orders placed by its own controlling investor. The financials underline the gap between hype and fundamentals - Enflame has racked up cumulative losses of about 4.29 billion yuan (roughly $600 million) over the past three years^[4], and its post-debut valuation ran nearly triple the 61.2 billion yuan valuation set at listing, and far above the roughly $2.8 billion it commanded in its last private funding round in 2023^[4][5].

Enflame's pitch as a domestic Nvidia alternative rests on its Cloud Flint T20 and T21 data-center accelerator chips^[6], but the scale of the challenge it faces is easy to lose in the excitement of a 179% pop. Nvidia alone still commands roughly 55% of China's AI accelerator server market, with the entire field of Chinese suppliers - Enflame included - holding a collective 41%^[3]. A blockbuster IPO changes Enflame's balance sheet and its profile with investors; it does not, by itself, change that market-share arithmetic.

Enflame is not an isolated phenomenon - it is the fourth and final member of what investors have nicknamed China's 'four little dragons' of AI chipmaking to reach the public market^[1]. Moore Threads listed first, in December 2025, raising $1.19 billion and gaining over 400% on its debut; MetaX followed the same month, raising $624.9 million and soaring nearly 700% on day one; Biren Technology listed in Hong Kong in January 2026, raising $897 million and jumping 76%^[4]. Morgan Stanley analysts have characterized the broader moment as "still at a very early stage of a multi-year IPO upcycle" for strategically important Chinese tech companies, even as many of the businesses going public remain unprofitable^[1]. Coverage of the Enflame debut has also flagged a more cautious pattern worth watching: scrutiny around whether Chinese tech stocks' first-day pops can survive contact with an actual earnings calendar, rather than fading into post-IPO slumps^[7]. Four consecutive triple-digit-percent debuts in under a year is either proof of durable structural demand for domestic chip alternatives, or a sign that the same pool of retail capital is simply chasing the same story four times.

The strong reception is inseparable from Beijing's policy backdrop. Coverage of Enflame's oversubscription frames the response as validation of China's accelerating push for semiconductor self-sufficiency amid US export restrictions on advanced AI chips^[2]. Enflame has already had to operate inside those restrictions directly: in June 2024 it submitted downgraded chip designs to TSMC to comply with US export-control rules, before formally announcing its STAR Market listing plans two months later with China International Capital Corporation as advisor^[6]. In other words, the same export-control regime that constrains what Enflame can build is also a large part of why investors are willing to pay up for a homegrown alternative, however early-stage.